218 related articles for article (PubMed ID: 38167865)
1. A naturally occurring variant of SHLP2 is a protective factor in Parkinson's disease.
Kim SJ; Miller B; Hartel NG; Ramirez R; Braniff RG; Leelaprachakul N; Huang A; Wang Y; Arpawong TE; Crimmins EM; Wang P; Sun X; Liu C; Levy D; Yen K; Petzinger GM; Graham NA; Jakowec MW; Cohen P
Mol Psychiatry; 2024 Feb; 29(2):505-517. PubMed ID: 38167865
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration.
Nashine S; Cohen P; Nesburn AB; Kuppermann BD; Kenney MC
Sci Rep; 2018 Oct; 8(1):15175. PubMed ID: 30310092
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.
Cobb LJ; Lee C; Xiao J; Yen K; Wong RG; Nakamura HK; Mehta HH; Gao Q; Ashur C; Huffman DM; Wan J; Muzumdar R; Barzilai N; Cohen P
Aging (Albany NY); 2016 Apr; 8(4):796-809. PubMed ID: 27070352
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profile of diet-induced obesity mice in response to humanin and small humanin-like peptide 2 treatment.
Mehta HH; Xiao J; Ramirez R; Miller B; Kim SJ; Cohen P; Yen K
Metabolomics; 2019 Jun; 15(6):88. PubMed ID: 31172328
[TBL] [Abstract][Full Text] [Related]
5. Plasma mitochondrial derived peptides MOTS-c and SHLP2 positively associate with android and liver fat in people without diabetes.
Sequeira IR; Woodhead JST; Chan A; D'Souza RF; Wan J; Hollingsworth KG; Plank LD; Cohen P; Poppitt SD; Merry TL
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129991. PubMed ID: 34419510
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of mitochondrial protein humanin rescues cell death and promotes mitochondrial function in Parkinson's disease.
Kim KH
Theranostics; 2023; 13(10):3330-3345. PubMed ID: 37351170
[No Abstract] [Full Text] [Related]
7. Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neurons.
Kim SK; Tran LT; NamKoong C; Choi HJ; Chun HJ; Lee YH; Cheon M; Chung C; Hwang J; Lim HH; Shin DM; Choi YH; Kim KW
Nat Commun; 2023 Jul; 14(1):4321. PubMed ID: 37468558
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in circulating mitochondria-derived peptides may contribute to prostate cancer health disparities.
Ramirez-Torres A; Reagan AL; Howard LE; Wiggins E; Vidal AC; Wan J; Miller B; Freedland SJ; Cohen P
Prostate; 2022 Sep; 82(13):1248-1257. PubMed ID: 35789022
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction.
Wang X; Petrie TG; Liu Y; Liu J; Fujioka H; Zhu X
J Neurochem; 2012 Jun; 121(5):830-9. PubMed ID: 22428580
[TBL] [Abstract][Full Text] [Related]
11. Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson's disease.
Franco-Iborra S; Cuadros T; Parent A; Romero-Gimenez J; Vila M; Perier C
Cell Death Dis; 2018 Nov; 9(11):1122. PubMed ID: 30405116
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial-derived peptides in energy metabolism.
Merry TL; Chan A; Woodhead JST; Reynolds JC; Kumagai H; Kim SJ; Lee C
Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E659-E666. PubMed ID: 32776825
[TBL] [Abstract][Full Text] [Related]
13. Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.
Lin CH; Chen ML; Chen GS; Tai CH; Wu RM
Hum Genet; 2011 Dec; 130(6):817-27. PubMed ID: 21701785
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants.
Lopez-Fabuel I; Martin-Martin L; Resch-Beusher M; Azkona G; Sanchez-Pernaute R; Bolaños JP
Neurochem Int; 2017 Oct; 109():101-105. PubMed ID: 28408307
[TBL] [Abstract][Full Text] [Related]
15. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.
Swerdlow RH
Antioxid Redox Signal; 2012 May; 16(9):950-64. PubMed ID: 21338319
[TBL] [Abstract][Full Text] [Related]
16. Low circulating levels of the mitochondrial-peptide hormone SHLP2: novel biomarker for prostate cancer risk.
Xiao J; Howard L; Wan J; Wiggins E; Vidal A; Cohen P; Freedland SJ
Oncotarget; 2017 Nov; 8(55):94900-94909. PubMed ID: 29212276
[TBL] [Abstract][Full Text] [Related]
17. [Mitochondrial disfunction in Parkinson's disease].
Buneeva OA; Medvedev AE
Biomed Khim; 2011; 57(3):246-81. PubMed ID: 21863741
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.
Das B; Dash SP; Mohanty S; Patel P
Adv Exp Med Biol; 2021; 1286():65-76. PubMed ID: 33725345
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ND5 mutations in idiopathic Parkinson's disease.
Parker WD; Parks JK
Biochem Biophys Res Commun; 2005 Jan; 326(3):667-9. PubMed ID: 15596151
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes.
Wang W; Wang X; Fujioka H; Hoppel C; Whone AL; Caldwell MA; Cullen PJ; Liu J; Zhu X
Nat Med; 2016 Jan; 22(1):54-63. PubMed ID: 26618722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
